Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semuloparin vs Enoxaparin for VTE Prevention in Knee Replacement
NCT00718224Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- May 2009
- Modality
- Peptides, Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of semuloparin in venous thromboembolism (VTE), sponsored by Sanofi. Started Jul 2008; status: completed.
02
Drugs
semuloparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00718224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718224.